Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Lizheng Hao"'
Publikováno v:
BMJ Open, Vol 11, Iss 9 (2021)
Objectives Derived neutrophil-to-lymphocytes ratio (dNLR) has recently been reported as a novel potential biomarker associated with prognosis of non-small cell lung cancer (NSCLC). However, evidence for the prognostic utility of dNLR in patients with
Externí odkaz:
https://doaj.org/article/79c9ebd47ec84a4d8ae803b62800a073
Autor:
Tao Yang, Lizheng Hao, Jian Chen, Xueying Zhu, Keyi Sun, Peipei Wang, Ji Lei, Xinyu Yang, Guoping Li, Min Jiang
Bruton's tyrosine kinase (BTK), a key B-cell and macrophage kinase, plays a pivotal role in oncogenic pathways in many B-cell malignancies. BTK inhibitors have shown promising anti-tumor activity, first in B-cell malignancies and subsequently in othe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::431a48119c12cc1fd1441421d2db5c5b
https://doi.org/10.21203/rs.3.rs-2278617/v1
https://doi.org/10.21203/rs.3.rs-2278617/v1
Background: Cancer poses a serious threat to human health. Clarifying the potential significance of Bruton's tyrosine kinase (BTK)in cancer has potential clinical value. This study examined the prognostic and immunological value of BTK gene expressio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3655c53c9a36b1926cdf6a2ce59538eb
https://doi.org/10.21203/rs.3.rs-876071/v1
https://doi.org/10.21203/rs.3.rs-876071/v1
Autor:
Changyong Luo, Caroline Lin Cai, Lizheng Hao, Guomi Wang, Xinyu Yang, Shuo Qi, Zhong Li, Tao Yang
Publikováno v:
BMJ Open
BMJ Open, Vol 11, Iss 9 (2021)
BMJ Open, Vol 11, Iss 9 (2021)
ObjectivesDerived neutrophil-to-lymphocytes ratio (dNLR) has recently been reported as a novel potential biomarker associated with prognosis of non-small cell lung cancer (NSCLC). However, evidence for the prognostic utility of dNLR in patients with
Publikováno v:
PeerJ
Background The immunological tumour microenvironment (TME) has occupied a very important position in the beginning and progression of non-small cell lung cancer (NSCLC). Prognosis of lung adenocarcinoma (LUAD) remains poor for the local progression a
Publikováno v:
PeerJ; Jan2021, p1-22, 22p